Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implications for immunotherapy of recurrent HSV infection

By York L.J.   Giorgio D.P.   Mishkin E.M.  

Vaccine, Vol. 13, Iss. 17, 1995-12 ,pp. : 1706-1712

Elsevier

Access to resources Recommend Favorite

Therapeutic vaccination against HSV-2: influence of vaccine formulation on immune responses and protection in mice

By Mohamedi S.A.   Heath A.W.   Jennings R.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1778-1792

Elsevier

Access to resources Recommend Favorite

Superiority of intramuscular route and full length glycoprotein D for DNA vaccination against herpes simplex 2. Enhancement of protection by the co-delivery of the GM-CSF gene

By Flo  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3242-3253

Elsevier

Access to resources Recommend Favorite

Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice

By Flo J.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1239-1245

Elsevier

Access to resources Recommend Favorite

Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I

By Kutinova L.   Ludvikova V.   Krystofova J.   Otavova M.   Simonova V.   Nemeckova S.   Hainz P.   Vonka V.  

Vaccine, Vol. 14, Iss. 11, 1996-08 ,pp. : 1045-1052

Elsevier

Access to resources Recommend Favorite